Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 0 | 18,000 | 0 | 0 | 0 |
| Gross Profit | N/A | 18,000 | N/A | N/A | N/A |
| Operating Expenses | 12,403 | 14,118 | 9,900 | 11,399 | 8,419 |
| Operating Income | -12,403 | 3,882 | -9,900 | -11,399 | -8,419 |
| Other Income | -201 | 215 | 82 | 58 | 189 |
| Pre-tax Income | -12,604 | 4,097 | -9,818 | -11,341 | -8,230 |
| Net Income Continuous | -12,604 | 4,097 | -9,818 | -11,341 | -8,230 |
| Net Income | $-12,604 | $4,097 | $-9,818 | $-11,341 | $-8,230 |
| EPS Basic Total Ops | -3.20 | 1.20 | -3.80 | -5.80 | -6.70 |
| EPS Basic Continuous Ops | -3.15 | 1.22 | -3.77 | -9.10 | -6.71 |
| EPS Diluted Total Ops | -3.20 | 1.20 | -3.80 | -5.80 | -6.70 |
| EPS Diluted Continuous Ops | -3.15 | 1.19 | -3.77 | -9.10 | -6.71 |
| EBITDA(a) | $-11,390 | $4,373 | $-10,053 | $-11,447 | $-8,373 |